Aijun Li
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA Interference and Gene Delivery
- Advanced biosensing and bioanalysis techniques
- RNA modifications and cancer
Papers in
-
- Advanced biosensing and bioanalysis techniques 4
- Circular RNAs in diseases 4
- RNA modifications and cancer 4
- Epigenetics and DNA Methylation 3
- RNA Interference and Gene Delivery 3
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 4
- Co-authors
- Xiangyang Shi (3 shared papers)Xueyan Cao (3 shared papers)Caifeng Liu (1 shared paper)Keji Chen (1 shared paper)Fei Fan (1 shared paper)Jieru Qiu (2 shared papers)Qingmei Xie (3 shared papers)Lingdan Kong (1 shared paper)
- Journals
- Environmental Monitoring and Assessment (2 papers)Oncotarget (2 papers)Journal of the Science of Food and Agriculture (1 paper)Hepatology International (1 paper)International Journal of Medical Sciences (1 paper)
- Partner nations
- ChinaUnited StatesPortugal
In The Last Decade
Aijun Li
28 papers receiving 623 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 209
- Molecular Biology 428
- Biomaterials 47
- Immunology 74
- Urology 17
Countries citing papers authored by Aijun Li
This map shows the geographic impact of Aijun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aijun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aijun Li more than expected).
Fields of papers citing papers by Aijun Li
This network shows the impact of papers produced by Aijun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aijun Li. The network helps show where Aijun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Aijun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 78 | |
| 2 | 2018 | 77 | |
| 3 | 2017 | 51 | |
| 4 | 2013 | 43 | |
| 5 | 1998 | 34 | |
| 6 | 2019 | 34 | |
| 7 | 2016 | 30 | |
| 8 | 2018 | 30 | |
| 9 | 2015 | 29 | |
| 10 | 2016 | 23 | |
| 11 | 2020 | 22 | |
| 12 | 2020 | 22 | |
| 13 | 2020 | 21 | |
| 14 | 2019 | 20 | |
| 15 | Spontaneous complete necrosis of hepatocellular carcinoma: a case report. | 2003 | 17 |
| 16 | 2018 | 15 | |
| 17 | 2023 | 13 | |
| 18 | 2018 | 13 | |
| 19 | 2022 | 11 | |
| 20 | 2020 | 11 |
About Aijun Li
Aijun Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Biotechnology and Surgery, having authored 28 papers that have together received 627 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Advanced biosensing and bioanalysis techniques (4 papers), Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (4 papers), RNA modifications and cancer (4 papers), Epigenetics and DNA Methylation (3 papers), RNA Interference and Gene Delivery (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Cancer Research (209 citations), Molecular Biology (428 citations), Biomaterials (47 citations), Immunology (74 citations) and Urology (17 citations). Aijun Li has collaborated with scholars based in China, United States and Portugal. Frequent co-authors include Xiangyang Shi, Xueyan Cao, Caifeng Liu, Keji Chen, Fei Fan, Jieru Qiu, Qingmei Xie, Lingdan Kong, Huanmin Zhang and Benqing Zhou. Their work appears in journals such as Environmental Monitoring and Assessment, Oncotarget, Journal of the Science of Food and Agriculture, Hepatology International and International Journal of Medical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.